What are the Challenges in Developing Nanotechnology-Based Drug Delivery Systems?
Despite the numerous benefits, there are several challenges associated with developing nanotechnology-based drug delivery systems:
Biocompatibility: Ensuring that nanocarriers are biocompatible and do not elicit an adverse immune response is crucial. Toxicity: Some nanoparticles may have inherent toxicity that could pose risks to patients. Manufacturing: Scaling up the production of nanocarriers while maintaining quality and consistency is a significant challenge. Regulatory Approval: Navigating the regulatory landscape for nanotechnology-based drug delivery systems can be complex and time-consuming. Cost: The development and production of nanocarriers can be expensive, potentially limiting their accessibility.
